Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Small Vessels Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Not applicableLooking for participantsNCT04962295
What this trial is testing

China Imaging-based Biobank of Cerebral Small Vessal Diseases

Who this might be right for
Cerebral Small Vessel Diseases
Peking University Third Hospital 10,000
Not applicableStudy completedNCT05495607
What this trial is testing

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Who this might be right for
Hypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more
Centre Hospitalier Universitaire de Nice 25
Not applicableNot Yet RecruitingNCT07650110
What this trial is testing

Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2

Who this might be right for
CADASILCavernous AngiomaCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy+1 more
Assistance Publique - Hôpitaux de Paris 600
Not applicableStudy completedNCT07136662
What this trial is testing

Anderson Fabry Disease - the Power of Information.

Who this might be right for
Fabry Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableEnded earlyNCT04999059
What this trial is testing

Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201

Who this might be right for
Fabry Disease
AVROBIO 5
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT03135197
What this trial is testing

German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.

Who this might be right for
Fabry Disease
University Hospital Muenster 75
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Large-scale testing (Phase 3)Study completedNCT03018730
What this trial is testing

Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)

Who this might be right for
Fabry Disease
Protalix 22
Not applicableStudy completedNCT02210130
What this trial is testing

The Microvascular Brain Retina And Kidney Study

Who this might be right for
Cerebral Small Vessels Disease
Fondation Ophtalmologique Adolphe de Rothschild 163
Not applicableStudy completedNCT04529642
What this trial is testing

Is the 6-Minute Walking Test Combined With an IMU Useful in Stroke Rehabilitation Assessment?

Who this might be right for
StrokePhysical Therapy ModalitiesGait Analysis
Fondazione Don Carlo Gnocchi ETS 46
Not applicableLooking for participantsNCT04310098
What this trial is testing

CADASIL Registry Study

Who this might be right for
Cadasil
Bin Cai 1,000
Not applicableEnded earlyNCT05699265
What this trial is testing

Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing

Who this might be right for
Fabry Disease
Children's Hospital Medical Center, Cincinnati 4
Early research (Phase 1)Study completedNCT00994500
What this trial is testing

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02489344
What this trial is testing

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 8
Not applicableActive Not RecruitingNCT05039866
What this trial is testing

Long-Term Follow-up of Subjects Who Were Treated With ST-920

Who this might be right for
Fabry DiseaseFabry Disease, Cardiac Variant
Sangamo Therapeutics 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692399
What this trial is testing

Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL

Who this might be right for
CADASIL
Huashan Hospital 60